Distinguished in AIDS Dysmorphic Syndrome

Dr. Juan Rondon

Internal Medicine
3157 N University Dr, Suite 103, 
Hollywood, FL 
Distinguished in AIDS Dysmorphic Syndrome
3157 N University Dr, Suite 103, 
Hollywood, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Juan Rondon is a primary care provider, practicing in Internal Medicine in Hollywood, Florida. Dr. Rondon is rated as a Distinguished provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

3157 N University Dr, Suite 103, Hollywood, FL 33024

Additional Areas of Focus

Dr. Rondon has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Pharmacokinetic Study of KW-6356 in Subjects With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
A Pharmacokinetic Study of KW-6356 in Subjects With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Enrollment Status: Completed
Publish Date: April 25, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2B, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversing Ticagrelor in Subjects Aged 50 to 80 Years Old
A Phase 2B, Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversing Ticagrelor in Subjects Aged 50 to 80 Years Old
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Drug
Study Phase: Phase 2
Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Phase 1 Pharmacokinetics and Safety Study of Oral Soticlestat in Participants With Moderate or Mild Hepatic Impairment and Normal Hepatic Function
Enrollment Status: Completed
Publish Date: February 02, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Single-Dose, Single-Center, Open-Label, Three-Arm Study to Assess the Tolerability and Safety of Immune Globulin Subcutaneous (Human), 20% Solution With Recombinant Human Hyaluronidase (TAK-881) at Various Infusion Rates in Healthy Adult Subject
A Phase 1, Single-Dose, Single-Center, Open-Label, Three-Arm Study to Assess the Tolerability and Safety of Immune Globulin Subcutaneous (Human), 20% Solution With Recombinant Human Hyaluronidase (TAK-881) at Various Infusion Rates in Healthy Adult Subject
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Biological
Study Phase: Phase 1
The Impact of Tirzepatide on Gastric Emptying (GE) in Overweight/Obese Non-diabetic Subjects and in Overweight/Obese Subjects With Type 2 Diabetes Mellitus
The Impact of Tirzepatide on Gastric Emptying (GE) in Overweight/Obese Non-diabetic Subjects and in Overweight/Obese Subjects With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: January 08, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Randomized Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-Up and No Ramp-Up Dosing in Healthy Adult Subjects
A Phase 1, Open-Label, Randomized Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-Up and No Ramp-Up Dosing in Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: December 14, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Placebo-Controlled, Double-Blinded Single and Multiple Ascending Dose (SAD and MAD) Study of the Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers
A Randomized, Placebo-Controlled, Double-Blinded Single and Multiple Ascending Dose (SAD and MAD) Study of the Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
Enrollment Status: Completed
Publish Date: March 28, 2022
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Aldafermin in Subjects With Impaired Hepatic Function
A Phase I, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Aldafermin in Subjects With Impaired Hepatic Function
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Biological
Study Phase: Phase 1
A Multiple-Dose Study in Participants With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of LY3502970
A Multiple-Dose Study in Participants With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of LY3502970
Enrollment Status: Completed
Publish Date: July 27, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 9 Less Clinical Trials

14 Total Publications

Pharmacokinetics of islatravir in participants with moderate hepatic impairment.
Pharmacokinetics of islatravir in participants with moderate hepatic impairment.
Journal: Antimicrobial agents and chemotherapy
Published: March 05, 2025
Similar Doctors
Distinguished in AIDS Dysmorphic Syndrome
Dr. Joseph R. Piperato
Internal Medicine
Distinguished in AIDS Dysmorphic Syndrome
Dr. Joseph R. Piperato
Internal Medicine

Project Access Foundation Inc

7000 Sw 62nd Ave, Suite 300, 
South Miami, FL 
 (23.1 miles away)
305-284-7666
Languages Spoken:
English, Italian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Piperato is a primary care provider, practicing in Internal Medicine in South Miami, Florida. Dr. Piperato is rated as a Distinguished provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are Myelitis, HIV/AIDS, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome. Dr. Piperato is currently accepting new patients.

Advanced in AIDS Dysmorphic Syndrome
Dr. Sheetal Sharma
Internal Medicine
Advanced in AIDS Dysmorphic Syndrome
Dr. Sheetal Sharma
Internal Medicine

Aids Healthcare Foundation

6333 N Federal Hwy, Suite 301 302, 
Fort Lauderdale, FL 
 (14.5 miles away)
954-772-2411
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sheetal Sharma is a primary care provider, practicing in Internal Medicine in Fort Lauderdale, Florida. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are Myelitis, HIV/AIDS, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Advanced in AIDS Dysmorphic Syndrome
Dr. Denise H. Cohen
Internal Medicine
Advanced in AIDS Dysmorphic Syndrome
Dr. Denise H. Cohen
Internal Medicine

North Broward Hospital District

5353 N Federal Hwy, Suite 300, 
Fort Lauderdale, FL 
 (13.5 miles away)
954-958-5190
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Denise Cohen is a primary care provider, practicing in Internal Medicine in Fort Lauderdale, Florida. Dr. Cohen is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, HIV/AIDS, AIDS Dementia Complex, and Pacemaker Implantation. Dr. Cohen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rondon's expertise for a condition
ConditionClose
      View All 32 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile